'Biosimilars' Were Supposed to Tame Costs for Drugs Like Humira. It Isn't Working.
AbbVie's arthritis treatment Humira and other biologics account for almost half of annual U.S. drug spending—but just 2% of prescriptions.
Stay updated with breaking news from Sny. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie's arthritis treatment Humira and other biologics account for almost half of annual U.S. drug spending—but just 2% of prescriptions.
Natixis Advisors L.P. increased its stake in shares of Sanofi (NASDAQ:SNY – Get Rating) by 93.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,687,635 shares of the company’s stock after purchasing an additional 813,365 shares during the quarter. Natixis Advisors L.P. […]
Nkcfo LLC boosted its stake in shares of Sanofi (NASDAQ:SNY – Get Rating) by 0.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 214,575 shares of the company’s stock after buying an additional 525 shares during the quarter. Sanofi makes up […]
Lineweaver Wealth Advisors LLC lessened its holdings in shares of Sanofi (NASDAQ:SNY – Get Rating) by 3.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,977 shares of the company’s stock after selling 1,053 shares during the quarter. Lineweaver Wealth Advisors LLC’s holdings in […]
Sanofi (NYSE:SNY – Get Rating) and AstraZeneca (OTCMKTS:AZNCF – Get Rating) are both health technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, dividends, profitability, risk and valuation. Analyst Recommendations This is a summary of recent ratings and price […]